How are the European pharma and biotech sectors addressing strategic communications?Stakeholder expectations are high and, with all eyes on healthcare at the moment, it is essential for companies Share XHow are the European pharma and biotech sectors addressing strategic communications?https://deep-dive.pharmaphorum.com/magazine/communications-and-commercialisation/european-pharma-biotech-strategic-communications/
BMS’ Catherine Owen: Hybrid communication is here to stayThe company’s senior vice president for major markets (Europe, Canada and Japan) talks about the continued evolution of Share XBMS’ Catherine Owen: Hybrid communication is here to stayhttps://deep-dive.pharmaphorum.com/magazine/communications-and-commercialisation/bristol-myers-squibb-bms-catherine-owen/
A Life in a Day by The MethodPatient centricity has become a key aspiration for the pharma industry over the last several years, but getting Share XA Life in a Day by The Methodhttps://deep-dive.pharmaphorum.com/magazine/communications-and-commercialisation/the-method-patient-empathy-engagement/
Translating EU presence to US market successCompanies looking to replicate a drug’s EU market success in the US will face significant hurdles unless they Share XTranslating EU presence to US market successhttps://deep-dive.pharmaphorum.com/magazine/communications-and-commercialisation/eu-us-pharma-market-success/
Navigating the patient maze – pharma’s evolving challengePharma companies are embracing patient centricity in drug development more than ever before. Over the last decade, leaders Share XNavigating the patient maze – pharma’s evolving challengehttps://deep-dive.pharmaphorum.com/magazine/communications-and-commercialisation/patient-pharma-engagement-drug-development/
It’s time to rethink the physician-pharma relationshipThe traditional sales channel for the pharmaceutical industry has centered on face-to-face interaction with its core target audience Share XIt’s time to rethink the physician-pharma relationshiphttps://deep-dive.pharmaphorum.com/magazine/communications-and-commercialisation/physician-pharma-relationships/
Refining digital collaborationPharmaceutical companies are traditionally more conservative with their approach to and incorporation of new technologies; however, prior to Share XRefining digital collaborationhttps://deep-dive.pharmaphorum.com/magazine/communications-and-commercialisation/pharma-hcp-digital-collaboration/
Closing pharma’s communication gap with patientsThe pharma industry has been talking about being patient-centric for years, but often that rhetoric hasn’t been accompanied Share XClosing pharma’s communication gap with patientshttps://deep-dive.pharmaphorum.com/magazine/communications-and-commercialisation/syneos-health-pharma-patient-communications/
Leveraging a strong product launch to build a successful pharma brandSo much effort goes into ensuring the successful launch of a new pharmaceutical product or indication, but it’s Share XLeveraging a strong product launch to build a successful pharma brandhttps://deep-dive.pharmaphorum.com/magazine/communications-and-commercialisation/product-launch-build-pharma-brand/
